Efficacy of vancomycin/tri-iododecyclemethyl ammonium chloride-coated ventriculostomy catheters in reducing infection

Neurosurgery

Volumn 40, Issue 5, 1997, Pages 1043-1049

  Hamilton, Allan J ^a   Orozco, Jose ^a   Narotam, Pradeep ^a   Bowersock, Terry ^b  

^a UNIVERSITY OF ARIZONA   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

Tri iododecyclemethyl ammonium chloride; Vancomycin; Ventriculostomy catheter

Indexed keywords

TRIIODODECYCLEMETHYL AMMONIUM CHLORIDE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANASTOMOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL GROWTH; BACTERIUM COLONY; BRAIN VENTRICLE; BRAIN VENTRICULITIS; CATHETER; DRUG EFFICACY; DRUG RELEASE; GROWTH INHIBITION; INFECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RABBIT; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 0030959296     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199705000-00031     Document Type: Article

References (43)

1. Andrew JH, Waters MJ: Hydrocephalus shunt infections and their treatment. J Antimicrob Chemother 18:145-146, 1986.
2. Aucoin PJ, Kotilainen HR, Gantz NM, Davidson R, Kellogg P, Stone B: Intracranial pressure monitors: Epidemiologic study of risk factors and infections. Am J Med 80:369-376, 1986.
3. Barrons RW, Murray KM, Richey RM: Populations at risk for penicillin-induced seizures. Ann Pharmacother 26:26-29, 1992.
4. Bering EA Jr: A simplified apparatus for constant ventricular drainage. J Neurosurg 8:450-452, 1951.
5. Brummett RE, Fox KE: Vancomycin- and erythromycin-induced hearing loss in humans. J Antimicrob Agents Chemother 33:791-796, 1989.
6. Chambers HF: Treatment of infection and colonization caused by methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 12:29-35, 1991.
7. Congeni BL, Tan J, Salstrom SJ, Weinstein L: Kinetics of vancomycin (V) after intraventricular and intravenous administration. Pediatr Res 13:459, 1979 (abstr).
8. Cradock JC, Kleinman LM, Davignon JP: Intrathecal injections: A review of pharmaceutical factors. Bull Parent Drug Assoc 31:237-247, 1977.
9. Diaz-Mitoma F, Harding GK, Hoban DJ, Roberts RS, Low DE: Clinical significance of a test for slime production in ventriculo-peritoneal shunt infections caused by coagulase-negative staphylococci. J Infect Dis 156:555-560, 1987.
10. Donetz AP, Harvey RA, Greco RS: Stability of antibiotics bound to polytetrafluoroethylene with cationic surfactants. J Clin Microbiol 19:1-3, 1984.
11. Fasola EL, Fasching CE, Peterson LR: Molecular correlation between in vitro and in vivo activity of beta-lactam and beta-lactamase inhibitor combinations against methicillin-resistant Staphylococcus aureus. J Lab Clin Med 125:200-211, 1995.
12. Franges EZ, Beideman MA: Infections related to intracranial pressure monitoring. J Neurosci Nurs 20:94-103, 1988.
13. Friedman WA, Vries JK: Percutaneous tunnel ventriculostomy: Summary of 100 procedures. J Neurosurg 53:662-665, 1980.
14. George R, Leibrock L, Epstein M: Long-term analysis of cerebrospinal fluid shunt infections: A 25-year experience. J Neurosurg 1:804-811, 1979.
15. Golledge CL, McKenzie T: Monitoring vancomycin concentrations in CSF after intraventricular administration. J Antimicrob Chemother 21:262-263, 1988 (letter).
16. Gump DW: Vancomycin for treatment of bacterial meningitis. Rev Infect Dis 3[Suppl]:289-292, 1981.
17. Hawley HB, Gump DW: Vancomycin therapy of bacterial meningitis. Am J Dis Child 126:261-264, 1973.
18. Jones CC, Cayard CH: Care of ICP monitoring devices: A nursing responsibility. J Neurosurg Nurs 14:255-261, 1982.
19. Kamal GD, Pfaller MA, Rempe LE, Jebson PJ: Reduced intravascular catheter infection by antibiotic bonding: A prospective, randomized, controlled trial. JAMA 265:2364-2368, 1991.
20. Kusske JA, Turner PT, Ojemann GA, Harris AB: Ventriculostomy for the treatment of acute hydrocephalus following subarachnoid hemorrhage. J Neurosurg 38:591-595, 1973.
21. Lee EL, Robinson MJ, Thong ML, Puthucheary SD, Ong TH, Ng KK: Intraventricular chemotherapy in neonatal meningitis. J Pediatr 91:991-995, 1977.
22. Lundberg N: Continuous recording and control of ventricular fluid pressure in neurosurgical practice. Acta Psychiatr Scand Suppl 149:1-193, 1960.
23. Lundberg N, Troupp H, Lorin H: Continuous recording of the ventricular-fluid pressure in patients with severe acute traumatic brain injury: A preliminary report. J Neurosurg 22:581-590, 1965.
24. Mayhall CG, Archer NH, Lamb AV, Spadora AC, Baggett JW, Ward JD, Narayan RK: Ventriculostomy-related infections: A prospective epidemiologic study. N Engl J Med 310:553-559, 1984.
25. Panlilio AL, Culver DH, Gaynes RP, Banerjee S, Henderson TS, Toison JS, Martone WJ: Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991. Infect Control Hosp Epidemiol 13: 582-586, 1992.
26. Paydarfar D, Eldridge FL, Wagner PG, Dowell RT: Neural respiratory responses to cortically induced seizures in cats. Respir Physiol 89:225-237, 1992.
27. Peters G, Locci R, Pulverer G: Adherence and growth of coagulase-negative staphylococci on surfaces of intravenous catheters. J Infect Dis 146:479-482, 1982.
28. Plotkin SA, McKitrick JC: Nosocomial meningitis of the newborn caused by a flavobacterium. JAMA 198:194-196, 1966.
29. Rieselbach RE, Freireich EF, Gaskins J, Rall DP: Distribution in subarachnoid space of materials injected by lumbar puncture. Clin Res 9:148, 1961 (abstr).
30. Rosner MJ, Becker DP: ICP monitoring: Complications and associated factors. Clin Neurosurg 23:494-519, 1976.
31. Schoenbaum SC, Gardner P, Shillito J: Infections of cerebrospinal fluid shunts: Epidemiology, clinical manifestations and therapy. J Infect Dis 131:543-552, 1975.
32. Schultz M, Moore K, Foote A: Bacterial ventriculitis and duration of ventriculostomy catheter insertion. J Neurosci Nurs 25:158-164, 1993.
33. Shurtleff DB, Foltz EL, Weeks RD, Loeser J: Therapy for Staphylococcus epidermidis: Infections associated with cerebrospinal fluid shunts. Pediatrics 53:55-62, 1974.
34. Smith RW, Alksne JF: Infections complicating the use of external ventriculostomy. J Neurosurg 44:567-570, 1976.
35. Stenager E, Gerner-Smidt P, Kock-Jensen C: Ventriculostomy-related infections and epidemiological study. Acta Neurochir (Wien) 83:20-23, 1986.
36. Sundbarg G, Kjallquist A, Lundberg N, Ponten U: Complications due to prolonged ventricular fluid pressure recording in clinical practice, in Brock M, Dietz H (eds): Intracranial Pressure: Experimental and Clinical Aspects. Berlin, Springer-Verlag, 1972, pp 348-352.
37. Swayne R, Rampling A, Newsom SW: Intraventricular vancomycin for treatment of shunt-associated ventriculitis. J Antimicrob Chemother 19:249-253, 1987.
38. Trooskin SZ, Donetz AP, Baxter J, Harvey RA, Greco RS: Infection-resistant continuous peritoneal dialysis catheters. Nephron 46:263-267, 1987.
39. Trooskin SZ, Donetz AP, Harvey RA, Greco RS: Prevention of catheter sepsis by antibiotic bonding. Surgery 97:547-551, 1985.
40. Wilhelm MP: Vancomycin. Mayo Clin Proc 66:1165-1170, 1991.
41. Wyler AR, Kelly WA: Use of antibiotics with external ventriculostomies. J Neurosurg 37:185-187, 1972.
42. Zar JH: Biostatistical Analysis. Englewood Cliffs, Prentice-Hall, Inc., 1996, pp 47-159.
43. Zeng YC, Pezzola A, Scotti De Carolis A, Sagratella S: Inhibitory influence of morphinans on ictal and interictal EEG changes induced by cortical application of penicillin in rabbits: A comparative study with NMDA antagonists and pentobarbitone. Pharmacol Biochem Behav 43:651-656, 1992.